This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The Schepens Eye Research Institute, Inc., Vegenics Pty Limited. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 133 
2 out of 22 
Years Active: 2019-2021
Title: The Innovative Contributions of Jie Ma in Ocular Research
Introduction
Jie Ma is a prominent inventor based in Boston, MA, known for his significant contributions to the field of ocular research. With a focus on age-related macular degeneration (AMD) and pathogenic ocular neovascularization, he has developed innovative treatments that aim to improve the quality of life for individuals suffering from these conditions. His work has led to the filing of two patents, showcasing his commitment to advancing medical science.
Latest Patents
Jie Ma's latest patents include groundbreaking applications directed towards the treatment of age-related macular degeneration and pathogenic ocular neovascularization. One of his notable inventions involves the use of a VEGF-C inhibitor, a VEGFR-2 inhibitor, and/or a VEGFR-3 inhibitor as a prophylactic or therapeutic approach for eye disorders. Additionally, his application emphasizes the use of VEGF-C measurements from biological samples as predictive markers for diseases such as maculopathy and pathogenic ocular neovascularization. These innovations represent a significant step forward in the diagnosis and treatment of serious eye conditions.
Career Highlights
Throughout his career, Jie Ma has worked with esteemed organizations such as Vegenics Pty Limited and The Schepens Eye Research Institute, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research. His dedication to ocular health has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Jie Ma has collaborated with notable professionals in his field, including Megan E Baldwin and Kameran Lashkari. These partnerships have fostered an environment of innovation and have led to the advancement of research in ocular disorders.
Conclusion
Jie Ma's contributions to ocular research through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments that address critical eye health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile